Langlai Technology
Langlai Technology is a clinical-stage innovative drug research and development company.
Series B+ ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredDec 9, 2020 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | ifastdata.com |
Timeline
- Website created
Investors
CChangjiang Capital
CChina Merchants Venturelead investor
GGF Qianhe Investment
LLilly Asia Ventures
PPICC Capital Investment Managementlead investor
- QQianhai Ark Capital
VVinno Capital
VVivo Capital
Companies like Langlai Technology
LLifeMine Therapeutics$75M Series B+ · Aug 2026
CCellCentric$220M Series B+ · May 2026
GGilgamesh Pharmaceuticals$60M Series A · Mar 2026
CCoologics$3M Seed · Apr 2025IIDRx$120M Series B+ · Aug 2024
FFormation Bio$372M Series B+ · Jun 2024
Other companies backed by China Merchants Venture
SSaigan TechnologySeed · Nov 2026
RRoboScienceSeries A · Nov 2026
SSleptaySeries A · Sep 2026
DDowsure
China Merchants Venture portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/langlai-technology (get a free API key).